| 1 |
Nilsson IM, Berntorp E, Lofqvist
T, Pettersson H. “Twenty five years experience of prophylactic
treatment in severe haemophilia A and B”
J Intern Med 1992;232:25-32.. |
| 2 |
Aledort L, Haschmeyer RH, Pettersson
H. “Orthopaedic outcome study group - a longitudinal study
of orthopaedic outcomes for severe factor-VIII deficient haemophiliacs”
J Intern Med 1994;236:391-399 |
| 3 |
UKHCDO guidelines : “Prophylaxis
in the treatment of haemophilic boys"
|
| 4 |
UKHCDO guidelines: “The
diagnosis and management of factor VIII and IX inhibitors”
British Journal of Haematology 2000;111:78-90. |
| 5 |
British HIV Association guidelines
for the treatment of HIV-infected adults with antiretroviral
therapy
HIV Medicine 2000;1:76-101. |
| 6 |
EASL International Consensus
Conference on Hepatitis C
Haemophilia 1999;5:365-370. |
| 7 |
UKHCDO guidelines: “Guidelines
on the diagnosis, management and prevention of hepatitis in
haemophilia”
Haemophilia 2001;7:339-345 |
| 8 |
NICE (National
Institute for Clinical Excellence) “Guidance on the use
of Ribavirin and Interferon Alpha for Hepatitis C.” October
2000. |
| 9 |
UKHCDO guidelines
: “Guidelines on therapeutic products to treat haemophilia
and other hereditary coagulation disorders”
Haemophilia 1997;3:63-77. |
| 10 |
Colowick A, Bohn
R, Avorn J, Ewenstien B “Immune tolerance induction in
haemophilia; costly can be cheaper”
Blood 2000;96:1698-1702. |
